By O +
Northern O +
blot O +
analysis O +
, O +
the O +
expression O +
of O +
IL O +
- O +
6 O +
mRNA O +
was O +
significantly O +
decreased O +
in O +
NUGC3 B-CellLine +
, O +
GBK B-CellLine +
- I-CellLine +
1 I-CellLine +
, O +
and O +
RERF B-CellLine +
- I-CellLine +
LCOK I-CellLine +
cells O +
but O +
was O +
increased O +
in O +
GaCa O +
cells O +
. O +

In O +
this O +
study O +
, O +
6 O +
different O +
cryoprotector O +
combinations O +
[ O +
dimethylsulfoxide O +
( O +
DMSO O +
) O +
, O +
ethylene O +
glycol O +
, O +
and O +
hydroxyethylstarch O +
( O +
HES O +
) O +
] O +
combined O +
with O +
2 O +
different O +
application O +
methods O +
were O +
screened O +
with O +
the O +
VUB01 B-CellLine +
cell O +
line O +
, O +
to O +
establish O +
a O +
new O +
slow O +
- O +
freezing O +
protocol O +
with O +
high O +
recovery O +
rates O +
and O +
a O +
good O +
expansion O +
capacity O +
. O +

Ma01 O +
caused O +
highly O +
lethal O +
infection O +
in O +
mice O +
with O +
severe O +
lung O +
pathology O +
and O +
extended O +
tissue O +
tropism O +
. O +

CCL O +
- O +
16 O +
was O +
overexpressed O +
by O +
over O +
130 O +
- O +
fold O +
in O +
IBS O +
- O +
constipation O +
patients O +
when O +
compared O +
with O +
both O +
controls O +
and O +
IBS O +
- O +
diarrhea O +
patients O +
. O +

The O +
EH B-CellLine +
- I-CellLine +
GB2 I-CellLine +
established O +
gallbladder O +
cancer O +
cell O +
line O +
is O +
useful O +
for O +
future O +
studies O +
of O +
gallbladder O +
cancer O +
development O +
, O +
progression O +
, O +
metastasis O +
and O +
therapy O +
. O +

Compound O +
1 O +
and O +
the O +
precursors O +
( O +
2 O +
, O +
3 O +
, O +
5 O +
, O +
and O +
7 O +
) O +
showed O +
antiproliferative O +
activities O +
against O +
human O +
K562 B-CellLine +
leukemia O +
, O +
murine O +
WEHI3 B-CellLine +
leukemia O +
, O +
and O +
murine O +
MEL B-CellLine +
erythroid O +
progenitor O +
. O +

Concerning O +
both O +
GSH O +
- O +
peroxidase O +
and O +
GSH O +
- O +
reductase O +
no O +
significant O +
differences O +
between O +
the O +
HLac B-CellLine +
79 I-CellLine +
subpopulations O +
were O +
observed O +
. O +

In O +
two O +
different O +
donors O +
, O +
we O +
identified O +
a O +
unique O +
peptide O +
in O +
the O +
NEF O +
protein O +
that O +
could O +
be O +
recognized O +
in O +
association O +
with O +
two O +
different O +
HLA O +
class O +
I O +
molecules O +
. O +

When O +
the O +
expression O +
of O +
E O +
- O +
cadherin O +
in O +
these O +
cells O +
was O +
examined O +
by O +
immunoblot O +
analysis O +
, O +
the O +
highly O +
metastatic O +
HM B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
was O +
found O +
to O +
express O +
an O +
extremely O +
small O +
amount O +
of O +
this O +
molecule O +
, O +
as O +
compared O +
with O +
a O +
high O +
level O +
of O +
E O +
- O +
cadherin O +
expression O +
in O +
the O +
weakly O +
metastatic O +
LM B-CellLine +
- I-CellLine +
1 I-CellLine +
and O +
LM B-CellLine +
- I-CellLine +
3 I-CellLine +
cells O +
. O +

The O +
KU B-CellLine +
- I-CellLine +
8 I-CellLine +
cell O +
line O +
was O +
established O +
from O +
a O +
lymph O +
node O +
metastasis O +
of O +
human O +
squamous O +
cell O +
carcinoma O +
( O +
SCC O +
) O +
of O +
the O +
penis O +
. O +

Speedy O +
restoration O +
of O +
immune O +
responsiveness O +
in O +
bone O +
marrow O +
recipients O +
has O +
been O +
the O +
objective O +
of O +
studies O +
in O +
which O +
the O +
donor O +
was O +
immunized O +
so O +
that O +
specific O +
immunologic O +
memory O +
could O +
be O +
transferred O +
adoptively O +
and O +
selectively O +
. O +

Molecular O +
cloning O +
and O +
expression O +
of O +
T11 O +
cDNAs O +
reveal O +
a O +
receptor O +
- O +
like O +
structure O +
on O +
human O +
T O +
lymphocytes O +
. O +

All O +
three O +
react O +
with O +
HL B-CellLine +
- I-CellLine +
60 I-CellLine +
( O +
promyelocytic O +
) O +
, O +
RWLeu4 B-CellLine +
( O +
CML O +
promyelocytic O +
) O +
, O +
and O +
U937 B-CellLine +
( O +
monocytic O +
) O +
, O +
but O +
not O +
with O +
KG B-CellLine +
- I-CellLine +
1 I-CellLine +
( O +
myeloblastic O +
) O +
or O +
K562 B-CellLine +
( O +
CML O +
erythroid O +
) O +
. O +

Herpes O +
Simplex O +
Virus O +
specified O +
DNA O +
- O +
binding O +
proteins O +
were O +
purified O +
from O +
virus O +
infected O +
VERO B-CellLine +
and O +
RAJI B-CellLine +
cells O +
. O +

The O +
human O +
thyroid O +
carcinoma O +
HTh7 B-CellLine +
spheroids O +
and O +
the O +
3 O +
types O +
of O +
human O +
glioma O +
spheroids O +
had O +
lower O +
quotients O +
. O +

COMMA B-CellLine +
- I-CellLine +
D I-CellLine +
cells O +
were O +
able O +
to O +
undergo O +
serial O +
passage O +
and O +
continued O +
to O +
exhibit O +
dome O +
formation O +
after O +
20 O +
passages O +
in O +
SFM O +
. O +

The O +
mol O +
wt O +
of O +
the O +
abnormal O +
receptors O +
in O +
human O +
leukemia O +
cells O +
was O +
the O +
same O +
as O +
the O +
mol O +
wt O +
of O +
receptors O +
in O +
mutant O +
mouse O +
lymphoma O +
cell O +
lines O +
, O +
S49 B-CellLine +
143R I-CellLine +
and O +
S49 B-CellLine +
55R I-CellLine +
, O +
which O +
have O +
the O +
nuclear O +
transfer O +
- O +
increased O +
phenotype O +
of O +
glucocorticoid O +
resistance O +
. O +

Human O +
recombinant O +
interferon O +
alpha O +
A O +
/ O +
D O +
( O +
alpha O +
A O +
/ O +
D O +
) O +
was O +
examined O +
for O +
its O +
antitumor O +
activity O +
in O +
several O +
mouse O +
tumor O +
models O +
using O +
metastatic O +
tumors O +
, O +
such O +
as O +
B16 B-CellLine +
melanoma I-CellLine +
F1 I-CellLine +
, O +
BL6 B-CellLine +
and O +
F10 B-CellLine +
, O +
UV2237 B-CellLine -
m I-CellLine +
fibrosarcoma O +
, O +
and O +
K1735 B-CellLine -
m I-CellLine +
melanoma O +
. O +

IL O +
- O +
1 O +
was O +
measured O +
by O +
its O +
property O +
of O +
promoting O +
the O +
production O +
of O +
interleukin O +
2 O +
( O +
IL O +
- O +
2 O +
) O +
by O +
phytohemagglutinin O +
- O +
treated O +
LBRM B-CellLine +
- I-CellLine +
33 I-CellLine +
clone I-CellLine +
1A5 I-CellLine +
cells O +
. O +

To O +
our O +
knowledge O +
, O +
RS4 B-CellLine +
; I-CellLine +
11 I-CellLine +
is O +
the O +
first O +
cell O +
line O +
established O +
from O +
t O +
( O +
4 O +
; O +
11 O +
) O +
- O +
associated O +
acute O +
leukemia O +
. O +

These O +
molecules O +
could O +
be O +
very O +
faintly O +
induced O +
in O +
PUTKO B-CellLine +
and O +
DUTKO B-CellLine +
hybrids O +
, O +
in O +
contrast O +
with O +
strong O +
HLA O +
class O +
- O +
II O +
expression O +
on O +
the O +
B O +
parental O +
lines O +
. O +

Two O +
human O +
melanoma O +
lines O +
, O +
RPMI B-CellLine +
- I-CellLine +
7931 I-CellLine +
and O +
HS B-CellLine +
- I-CellLine +
294 I-CellLine +
, O +
respond O +
to O +
mitogenic O +
stimulation O +
by O +
PHA O +
. O +

[ O +
Pharmacology O +
: O +
antihistaminics O +
H1 O +
receptor O +
blockaders O +
] O +

From O +
analysis O +
of O +
binding O +
patterns O +
in O +
various O +
tissues O +
and O +
in O +
immunoblots O +
, O +
it O +
was O +
found O +
that O +
RBA2 O +
cross O +
- O +
reacted O +
strongly O +
with O +
glial O +
fibrillary O +
acidic O +
protein O +
( O +
GFAP O +
) O +
and O +
desmin O +
. O +

In O +
limiting O +
dilution O +
cultures O +
, O +
most O +
normal O +
resting O +
splenic O +
B O +
cells O +
or O +
WEHI B-CellLine +
- I-CellLine +
279 I-CellLine +
B O +
tumor O +
cells O +
are O +
inducible O +
by O +
BMF O +
. O +

RLD B-CellLine +
cells O +
are O +
able O +
to O +
differentiate O +
after O +
in O +
vitro O +
stimulation O +
with O +
1 O +
% O +
DMSO O +
or O +
with O +
30 O +
nM O +
tetradecanoylphorbol O +
- O +
1 O +
. O +
3 O +
- O +
acetate O +
( O +
TPA O +
) O +
. O +

Human O +
amnion O +
CCL B-CellLine +
- I-CellLine +
25 I-CellLine +
cells O +
, O +
human O +
embryonic O +
intestine O +
CCL B-CellLine +
- I-CellLine +
6 I-CellLine +
cells O +
, O +
human O +
colon O +
adenocarcinoma O +
LOVO B-CellLine +
cells O +
, O +
and O +
mouse O +
hepatoma O +
BW O +
- O +
1 O +
cells O +
were O +
used O +
. O +

In O +
additional O +
studies O +
, O +
the O +
cytostatic O +
effects O +
of O +
activated O +
macrophages O +
markedly O +
reduced O +
the O +
cytotoxic O +
effects O +
of O +
the O +
chemotherapeutic O +
agent O +
cytosine O +
arabinoside O +
on O +
EMT B-CellLine +
- I-CellLine +
6 I-CellLine +
target O +
cells O +
. O +

Six O +
commonly O +
used O +
strains O +
of O +
lymphocytic O +
choriomeningitis O +
virus O +
( O +
LCMV O +
) O +
[ O +
Armstrong O +
( O +
Arm O +
) O +
CA O +
1371 O +
, O +
Arm O +
E O +
- O +
350 O +
, O +
WE O +
, O +
UBC O +
, O +
Traub O +
and O +
Pasteur O +
C1PV O +
76001 O +
] O +
were O +
examined O +
for O +
distinctive O +
genetic O +
and O +
biological O +
properties O +
. O +

[ O +
Development O +
of O +
leukemia O +
L B-CellLine +
- I-CellLine +
1210 I-CellLine +
after O +
treatment O +
with O +
the O +
methionine O +
synthetase O +
inhibitor O +
quinoline O +
dibromide O +
] O +

The O +
expression O +
of O +
the O +
DCC O +
( O +
deleted O +
in O +
colorectal O +
cancer O +
) O +
gene O +
, O +
located O +
on O +
the O +
chromosome O +
18q21 O +
, O +
was O +
extremely O +
reduced O +
in O +
KML B-CellLine +
- I-CellLine +
1 I-CellLine +
cell O +
line O +
, O +
as O +
compared O +
with O +
that O +
in O +
a O +
normal O +
spleen O +
tissue O +
and O +
other O +
4 O +
lymphoma O +
cell O +
lines O +
by O +
the O +
reverse O +
transcription O +
- O +
polymerase O +
- O +
chain O +
- O +
reaction O +
( O +
RT O +
- O +
PCR O +
) O +
method O +
. O +

After O +
a O +
4 O +
- O +
week O +
placebo O +
run O +
- O +
in O +
period O +
, O +
228 O +
patients O +
were O +
randomized O +
to O +
4 O +
weeks O +
of O +
treatment O +
with O +
either O +
NIF O +
CC O +
30 O +
mg O +
daily O +
or O +
NIF O +
GITS O +
30 O +
mg O +
daily O +
. O +

Northern O +
blot O +
analysis O +
showed O +
that O +
the O +
expression O +
levels O +
of O +
2d O +
- O +
29 O +
and O +
2d O +
- O +
35 O +
in O +
the O +
brain O +
were O +
lower O +
than O +
that O +
of O +
P450 O +
2D4 O +
in O +
the O +
liver O +
. O +

Fifteen O +
percent O +
of O +
EGF O +
receptors O +
present O +
on O +
differentiated O +
HT29 B-CellLine +
- I-CellLine +
D4 I-CellLine +
cells O +
were O +
localized O +
in O +
the O +
apical O +
surface O +
, O +
whereas O +
98 O +
% O +
of O +
IGF O +
- O +
I O +
receptors O +
were O +
segregated O +
to O +
the O +
basolateral O +
domain O +
. O +

KE B-CellLine +
- I-CellLine +
97 I-CellLine +
is O +
mucinous O +
carcinoma O +
, O +
and O +
it O +
was O +
reported O +
with O +
the O +
belief O +
that O +
it O +
is O +
a O +
useful O +
cell O +
line O +
upon O +
the O +
investigation O +
of O +
its O +
cancer O +
metastasis O +
mechanism O +
and O +
cytological O +
characteristics O +
. O +

The O +
inferred O +
amino O +
acid O +
sequences O +
of O +
rat O +
liver O +
CBS O +
and O +
rat O +
liver O +
hemoprotein O +
H O +
- O +
450 O +
are O +
identical O +
. O +

Swine B-CellLine +
testis I-CellLine +
cells O +
contain O +
functional O +
heparan O +
sulfate O +
but O +
are O +
defective O +
in O +
entry O +
of O +
herpes O +
simplex O +
virus O +
. O +

The O +
addition O +
of O +
anti O +
- O +
HGF O +
antibodies O +
to O +
cultures O +
of O +
SBC B-CellLine +
- I-CellLine +
5 I-CellLine +
cells O +
specifically O +
inhibited O +
spreading O +
and O +
motility O +
of O +
the O +
cells O +
without O +
affecting O +
growth O +
, O +
and O +
the O +
conditioned O +
medium O +
of O +
SBC B-CellLine +
- I-CellLine +
5 I-CellLine +
cells O +
also O +
induced O +
scattering O +
of O +
other O +
lineage O +
lung O +
carcinoma O +
. O +

Transforming O +
growth O +
factor O +
beta O +
( O +
TGF O +
beta O +
) O +
( O +
1 O +
ng O +
/ O +
ml O +
) O +
did O +
not O +
influence O +
whole O +
cell O +
alkaline O +
phosphatase O +
levels O +
in O +
UMR B-CellLine +
201 I-CellLine +
cells O +
. O +

Therefore O +
, O +
we O +
examined O +
the O +
influence O +
of O +
the O +
exposure O +
time O +
and O +
the O +
sequence O +
of O +
modulator O +
administration O +
on O +
the O +
active O +
transport O +
of O +
the O +
fluorescent O +
dye O +
rhodamine O +
123 O +
( O +
R123 O +
) O +
, O +
a O +
substrate O +
for O +
the O +
P O +
- O +
glycoprotein O +
, O +
in O +
the O +
resistant O +
lymphoblastoid O +
cell O +
line O +
VCR1000 B-CellLine +
and O +
the O +
parental O +
nonresistant O +
cell O +
line O +
CCRF B-CellLine +
- I-CellLine +
CEM I-CellLine +
. O +

No O +
DHT O +
and O +
cyproterone O +
acetate O +
effects O +
on O +
the O +
androgen O +
receptor O +
negative O +
line O +
UM B-CellLine +
- I-CellLine +
SCC11B I-CellLine +
were O +
found O +
. O +

Normal O +
human O +
fibroblasts O +
( O +
the O +
OUMS B-CellLine +
- I-CellLine +
24 I-CellLine +
strain O +
) O +
, O +
derived O +
from O +
a O +
6 O +
- O +
week O +
- O +
old O +
human O +
embryo O +
, O +
were O +
transformed O +
( O +
into O +
the O +
OUMS B-CellLine +
- I-CellLine +
24F I-CellLine +
line O +
) O +
and O +
immortalized O +
by O +
repeated O +
treatments O +
( O +
59 O +
times O +
) O +
with O +
4 O +
- O +
nitroquinoline O +
1 O +
- O +
oxide O +
( O +
4NQO O +
) O +
. O +

The O +
Kasumi B-CellLine +
- I-CellLine +
4 I-CellLine +
cells O +
had O +
the O +
following O +
characteristic O +
features O +
: O +
undifferentiated O +
blasts O +
which O +
were O +
positive O +
from O +
CD34 O +
, O +
CD33 O +
and O +
CD13 O +
surface O +
markers O +
, O +
but O +
negative O +
for O +
myeloperoxidase O +
platelet O +
peroxidase O +
, O +
CD36 O +
, O +
CD41 O +
and O +
CD42 O +
; O +
chromosome O +
abnormalities O +
of O +
t O +
( O +
9 O +
; O +
22 O +
; O +
11 O +
) O +
( O +
q34 O +
; O +
q11 O +
; O +
q13 O +
) O +
, O +
inv O +
( O +
3 O +
) O +
( O +
q21q26 O +
) O +
; O +
and O +
elevated O +
expression O +
of O +
EVI1 O +
gene O +
which O +
is O +
located O +
at O +
chromosome O +
band O +
3q26 O +
. O +

The O +
gp130 O +
- O +
associated O +
cytokines O +
, O +
IL O +
- O +
11 O +
, O +
leukemia O +
inhibitory O +
factor O +
and O +
oncostatin O +
M O +
, O +
stimulated O +
the O +
growth O +
of O +
the O +
KAS B-CellLine +
- I-CellLine +
6 I-CellLine +
/ I-CellLine +
1 I-CellLine +
cells O +
, O +
but O +
had O +
minimal O +
effects O +
on O +
the O +
DP B-CellLine +
- I-CellLine +
6 I-CellLine +
and O +
KP B-CellLine +
- I-CellLine +
6 I-CellLine +
cells O +
. O +

Responses O +
to O +
cisplatin O +
essentially O +
reported O +
low O +
sensitivity O +
of O +
OC B-CellLine +
314 I-CellLine +
and O +
OC B-CellLine +
315 I-CellLine +
and O +
resistance O +
of O +
OC B-CellLine +
316 I-CellLine +
, O +
thus O +
reflecting O +
the O +
original O +
sensitivity O +
at O +
the O +
clinical O +
level O +
. O +

Introduction O +
of O +
a O +
plasmid O +
carrying O +
an O +
fbpA O +
- O +
cat O +
transcriptional O +
fusion O +
in O +
E O +
. O +
coli O +
H1717 O +
( O +
Fur O +
+ O +
) O +
resulted O +
in O +
an O +
88 O +
% O +
induction O +
of O +
chloramphenicol O +
acetyltransferase O +
expression O +
under O +
conditions O +
of O +
iron O +
restriction O +
; O +
however O +
, O +
chloramphenicol O +
acetyltransferase O +
expression O +
was O +
not O +
responsive O +
to O +
iron O +
in O +
E O +
. O +
coli O +
H1745 O +
( O +
Fur O +
- O +
) O +
, O +
indicating O +
that O +
transcriptional O +
regulation O +
of O +
fbpA O +
in O +
response O +
to O +
iron O +
occurs O +
via O +
the O +
negative O +
regulator O +
Fur O +
. O +

Transfection O +
analysis O +
in O +
the O +
pancreatic O +
cell O +
line O +
HIT B-CellLine +
T I-CellLine +
- I-CellLine +
15 I-CellLine +
M O +
2 O +
. O +
2 O +
. O +
2 O +
revealed O +
that O +
a O +
DNA O +
fragment O +
containing O +
this O +
region O +
causes O +
a O +
45 O +
% O +
reduction O +
in O +
promoter O +
activity O +
when O +
linked O +
to O +
the O +
native O +
insulin O +
promoter O +
and O +
a O +
72 O +
% O +
reduction O +
when O +
linked O +
to O +
a O +
heterologous O +
tk O +
promoter O +
. O +

NR6W B-CellLine +
cells O +
demonstrated O +
a O +
saturation O +
binding O +
curve O +
with O +
125I O +
- O +
labeled O +
EGF O +
( O +
affinity O +
, O +
1 O +
. O +
8 O +
x O +
10 O +
( O +
8 O +
) O +
; O +
r2 O +
= O +
0 O +
. O +
96 O +
) O +
. O +

In O +
contrast O +
, O +
no O +
difference O +
in O +
adhesion O +
to O +
LAK O +
cells O +
and O +
susceptibility O +
to O +
LAK O +
cytotoxicity O +
was O +
detected O +
between O +
baseline O +
and O +
TNF O +
- O +
alpha O +
- O +
treated O +
NCI B-CellLine +
H838 I-CellLine +
cells O +
. O +

A O +
unique O +
immunohistochemical O +
approach O +
of O +
introducing O +
ascites O +
fluid O +
OX O +
- O +
27 O +
as O +
the O +
primary O +
antibody O +
intravenously O +
to O +
the O +
PVG O +
- O +
RT1U O +
host O +
demonstrated O +
that O +
in O +
donor O +
PVG O +
- O +
RT1C O +
posterior O +
pituitary O +
allografts O +
, O +
donor O +
and O +
not O +
host O +
vessels O +
predominate O +
and O +
are O +
restricted O +
to O +
the O +
graft O +
. O +

The O +
Lu B-CellLine +
- I-CellLine +
134A I-CellLine +
cells O +
adhered O +
to O +
the O +
substrate O +
and O +
developed O +
elongated O +
cytoplasmic O +
processes O +
which O +
gradually O +
grew O +
into O +
long O +
neuronal O +
- O +
like O +
processes O +
. O +

The O +
galanin O +
receptors O +
expressed O +
in O +
CHP B-CellLine +
- I-CellLine +
212 I-CellLine +
cells O +
, O +
like O +
GALR1 O +
have O +
high O +
affinity O +
for O +
galanin O +
( O +
Kd O +
= O +
0 O +
. O +
07 O +
nM O +
) O +
and O +
the O +
potency O +
for O +
inhibition O +
of O +
125I O +
- O +
galanin O +
binding O +
by O +
galanin O +
peptides O +
parallels O +
that O +
of O +
hGALR1 O +
expressed O +
in O +
a O +
stable O +
CHO B-CellLine +
cell O +
line O +
. O +

A O +
single O +
intraperitoneal O +
injection O +
of O +
the O +
replication O +
- O +
deficient O +
adenovirus O +
containing O +
the O +
HST O +
- O +
1 O +
gene O +
( O +
Adex1HST O +
- O +
1 O +
) O +
into O +
mice O +
caused O +
a O +
two O +
- O +
fold O +
increase O +
in O +
peripheral O +
platelet O +
count O +
for O +
30 O +
days O +
, O +
and O +
effectively O +
prevented O +
experimentally O +
induced O +
thrombocytopenia O +
. O +

In O +
a O +
cell O +
clone O +
derived O +
from O +
line O +
VMCub1 B-CellLine +
by O +
stable O +
transfection O +
with O +
wild O +
- O +
type O +
p53 O +
under O +
the O +
control O +
of O +
a O +
metallothionein O +
promotor O +
, O +
p21 O +
was O +
induced O +
along O +
with O +
p53 O +
upon O +
activation O +
of O +
the O +
promoter O +
with O +
zinc O +
chloride O +
. O +

Peptides O +
derived O +
from O +
CDR1 O +
of O +
44aacb O +
, O +
CDR2 O +
of O +
118 O +
. O +
1 O +
, O +
and O +
CDRs O +
1 O +
and O +
3 O +
of O +
MY904 O +
heavy O +
chains O +
were O +
found O +
to O +
possess O +
blocking O +
activity O +
at O +
10 O +
- O +
100 O +
muM O +
. O +

The O +
cell O +
lines O +
OCM B-CellLine +
- I-CellLine +
1 I-CellLine +
and O +
OMM B-CellLine +
- I-CellLine +
1 I-CellLine +
expressed O +
MAGE O +
- O +
1 O +
, O +
- O +
2 O +
and O +
- O +
3 O +
, O +
whereas O +
EOM B-CellLine +
- I-CellLine +
3 I-CellLine +
, O +
MEL202 B-CellLine +
, O +
92 B-CellLine +
- I-CellLine +
1 I-CellLine +
and O +
OMM B-CellLine +
- I-CellLine +
3 I-CellLine +
were O +
negative O +
for O +
these O +
antigens O +
. O +

Parsley O +
cells O +
recognize O +
the O +
fungal O +
phytopathogen O +
Phytophthora O +
sojae O +
through O +
a O +
plasma O +
membrane O +
receptor O +
. O +

Of O +
note O +
, O +
three O +
of O +
the O +
four O +
c O +
- O +
met O +
+ O +
lines O +
belonged O +
to O +
the O +
category O +
Hodgkin O +
- O +
ALCL O +
; O +
the O +
Hodgkin O +
cell O +
line O +
SUP B-CellLine +
- I-CellLine +
HD I-CellLine +
- I-CellLine +
1 I-CellLine +
showed O +
both O +
HGF O +
and O +
c O +
- O +
met O +
mRNA O +
bands O +
suggesting O +
the O +
possibility O +
of O +
an O +
autocrine O +
loop O +
. O +

Single O +
- O +
cell O +
suspensions O +
( O +
UF B-CellLine +
- I-CellLine +
1 I-CellLine +
/ O +
GMTg O +
SCID O +
cells O +
) O +
were O +
similar O +
in O +
morphological O +
, O +
immunological O +
, O +
cytogenetic O +
and O +
molecular O +
genetic O +
features O +
to O +
parental O +
UF B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
. O +

A O +
172 O +
bp O +
genomic O +
fragment O +
flanking O +
the O +
untranslated O +
exon O +
produced O +
a O +
high O +
level O +
of O +
expression O +
of O +
a O +
reporter O +
gene O +
in O +
transient O +
transfection O +
assays O +
using O +
a O +
human O +
lung O +
adenocarcinoma O +
cell O +
line O +
. O +

